Lab News

Prof. (Dr.) Mirza S. Baig visited IIT- Abu Dhabi

Prof. (Dr.) Mirza S. Baig visited IIT- Abu Dhabi

During the academic visit to IIT-Abu Dhabi, Prof. Baig met with IIT-Abu Dhabi officials. He shared his experience of being involved during the development of IIT Indore and appreciated the administration for their untiring efforts to develop the IIT in Abu Dhabi. Prof. Baig says, "I am proud to be a part of the global IIT fraternity."

Eventful Visit of Prof. Mirza S. Baig to BITS Dubai

Eventful Visit of Prof. Mirza S. Baig to BITS Dubai

Prof. Mirza S. Baig was invited to the Birla Institute of Technology & Science (BITS) Dubai campus. He delivered a lecture on current therapeutic strategies for chronic inflammatory diseases. During the visit, Prof. Baig interacted with faculty and students to discuss the reserch projects. The visit was deemed a success, as it resulted in the possibility of future collaboration and joint research projects in the area of cancer and chronic inflammatory diseases between BITS Dubai and Prof. Baig's home institution, IIT Indore.

Fellow of Royal Society of Biology (FRSB)

Fellow of Royal Society of Biology (FRSB)

Congratulations Prof. Baig for being elected as a Fellow of the Royal Society of Biology (FRSB)

Congratulations! The paper got accepted in Life Sciences

Congratulations! The paper got accepted in Life Sciences

An improved mouse model of sepsis based on intraperitoneal injections of the enriched culture of cecum slurry 

Fruitful collaborative research visit to Tohoku University

Fruitful collaborative research visit to Tohoku University

Prof. Mirza S. Baig and his research team have been invited to Tohoku University, Japan under the Sakura Invitational Program 2023. The team visited the Biomedical Engineering Cancer Research Center at Tohoku University to share their research with eminent scientists. The visit was hosted by the world-renowned scientist Prof. Tetsuya Kodama. The visit resulted in a fruitful outcome in terms of the possibility of future collaboration and joint research projects in the area of cancer immunotherapy.